会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 82. 发明申请
    • TAXOIDS, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
    • 紫杉醇,其制备方法及含有其的药物组合物
    • WO1997032869A1
    • 1997-09-12
    • PCT/FR1997000386
    • 1997-03-05
    • RHONE-POULENC RORER S.A.BOUCHARD, HervéBOURZAT, Jean-DominiqueCOMMERCON, Alain
    • RHONE-POULENC RORER S.A.
    • C07D305/14
    • C07D305/14Y02P20/55
    • Novel taxoids of general formula (I), the preparation thereof and pharmaceutical compositions containing same, are disclosed. In general formula (I), Z is a hydrogen atom or a radical of general formula (II), wherein R1 is an optionally substituted benzoyl radical or a radical R2-O-CO-, where R2 is an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, optionally substituted phenyl or heterocyclyl radical; R3 is an alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, naphthyl or aromatic heterocyclic radical; R4 is a hydroxy radical or an alkoxy, alkenyloxy, optionally substituted alkynyloxy, alkanoyloxy, alkenoyloxy, alkynyloxy, alkoxyacetyl or alkyloxycarbonyloxy radical, or a cycloalkyloxy, cycloalkenyloxy, arylcarbonyloxy or heterocyclylcarbonyloxy radical; and R5 is an optionally substituted alkoxy radical or a cycloalkyloxy or cycloalkenyloxy radical. The novel compounds of general formula (I), wherein Z is a radical of general formula (II), have remarkable antitumoral and antineoplastic properties.
    • 公开了通式(I)的新型紫杉烷类,其制备方法和含有其的药物组合物。 在通式(I)中,Z是氢原子或通式(II)的基团,其中R 1是任选取代的苯甲酰基或基团R 2 -O-CO-,其中R 2是烷基,烯基,炔基, 环烷基,环烯基,双环烷基,任选取代的苯基或杂环基; R3是烷基,烯基,炔基,环烷基,苯基,萘基或芳族杂环基; R4是羟基或烷氧基,烯氧基,任选取代的炔氧基,烷酰氧基,烯酰氧基,炔氧基,烷氧基乙酰基或烷氧基羰基氧基,或环烷氧基,环烯基氧基,芳基羰基氧基或杂环基羰基氧基; 并且R 5是任选取代的烷氧基或环烷氧基或环烯氧基。 通式(I)的新化合物,其中Z为通式(II)的基团,具有显着的抗肿瘤和抗肿瘤性质。
    • 89. 发明申请
    • 4,9-ETHANO-BENZO(F)ISOINDOLE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS
    • 4,9-ETHANO-BENZO(F)作为FARNESYL转移酶抑制剂的ISO衍生物
    • WO1997003050A1
    • 1997-01-30
    • PCT/FR1996001062
    • 1996-07-08
    • RHONE-POULENC RORER S.A.COMMERÇON, AlainLEBRUN, AlainMAILLIET, PatrickPEYRONEL, Jean-FrançoisSOUNIGO, FabienneTRUCHON, AlainZUCCO, Martine
    • RHONE-POULENC RORER S.A.
    • C07D209/72
    • C07D209/72C07F9/5728
    • Novel products of general formula (I), preparation thereof and pharmaceutical compositions containing said products are disclosed. In general formula (I), R is a radical of general formula -(CH2)m-X1-(CH2)n-Z, where X1 is a simple bond or O or S, n is 0 or 1 and n is 0, 1 or 2, the CH2 radicals being optionally substituted by carboxy, alkoxycarbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, amino, alkylamino or dialkylamino, and Z is carboxy, COOR4, where R4 is alkyl, or CON(R5)(R6), where R5 is hydrogen or alkyl and R6 is hydrogen or optionally substituted alkyl, or else R5 is hydrogen or alkyl and R6 is hydroxy, optionally substituted alkyloxy or amino, or PO(OR7)2, where R7 is hydrogen or alkyl; or a radical -NH-CO-T where T is hydrogen or optionally substituted alkyl; or else a radical (a); R1 and R2 are hydrogen or halogen or optionally substituted alkyloxy or alkyl, or else R1 and R2 in ortho positions form a heterocyclic ring containing 1 or 2 optionally substituted heteroatoms, or R1 is hydrogen or halogen or optionally substituted alkyloxy or alkyl, and R2 is thioalkyl; R3 is hydrogen or halogen or alkyl, alkenyl, alkyloxy, alkylthio, carboxy or alkyloxycarbonyl; X is O or S or -NH-, -CO-, methylene, ethylene, alkylidene or 1,1-cycloalkyl; and Y is O or S. The novel products of general formula (I) are farnesyl transferase inhibitors having remarkable antitumoral and antineoplastic properties.
    • 公开了通式(I)的新产品,其制备方法和含有所述产物的药物组合物。 在通式(I)中,R为通式 - (CH2)m-X1-(CH2)nZ的基团,其中X1为单键或O或S,n为0或1,n为0,1或 2,CH2基任选被羧基,烷氧基羰基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,氨基,烷基氨基或二烷基氨基取代,Z是羧基,COOR4,其中R4是烷基或CON(R5)(R6),其中R5是氢 或烷基,R 6是氢或任选取代的烷基,或者R 5是氢或烷基,R 6是羟基,任选取代的烷氧基或氨基或PO(OR 7)2,其中R 7是氢或烷基; 或其中T为氢或任选取代的烷基的基团-NH-CO-T; 或者一个激进的(a); R 1和R 2是氢或卤素或任选取代的烷氧基或烷基,或者R 1和R 2在邻位形成含有1或2个任选取代的杂原子的杂环,或R 1是氢或卤素或任选取代的烷氧基或烷基,R 2是 硫代; R3是氢或卤素或烷基,烯基,烷氧基,烷硫基,羧基或烷氧基羰基; X是O或S或-NH-,-CO-,亚甲基,亚乙基,亚烷基或1,1-环烷基; 并且Y是O或S.通式(I)的新产物是具有显着抗肿瘤和抗肿瘤性质的法呢基转移酶抑制剂。